Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: Results of a prospective, randomized, double-blind clinical trial

Otology and Neurotology

Volumn 28, Issue 4, 2007, Pages 455-458

  Olzowy, Bernhard ^a   Canis, Martin ^a   Hempel, John Martin ^a   Mazurek, Birgit ^b   Suckfüll, Markus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atorvastatin; Presbycusis; Prevention; Sensorineural hearing loss; Statins; Tinnitus

Indexed keywords

ATORVASTATIN; PLACEBO; CHOLESTEROL; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRROLE DERIVATIVE;

ADULT; AGED; ARTICLE; AUDIOMETRY; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; PERCEPTION DEAFNESS; PRESBYACUSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STUDENT T TEST; TINNITUS; AUDITORY THRESHOLD; BLOOD; DISEASE COURSE; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; SPEECH PERCEPTION; TREATMENT OUTCOME;

AGED; AUDIOMETRY; AUDITORY THRESHOLD; CHOLESTEROL; CHOLESTEROL, LDL; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HEARING LOSS, SENSORINEURAL; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PRESBYCUSIS; PROSPECTIVE STUDIES; PYRROLES; SPEECH PERCEPTION; TINNITUS; TREATMENT OUTCOME;

EID: 34447644415     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000271673.33683.7b     Document Type: Article

References (10)

1. Gates G, Cobb J, D'Agostino R, Wolf P. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg 1993;119:156-61.
2. Feron O, Dessy C, Desager JP, Balligand JL. Hydroxymethylglutaryl- coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 2001;103:113-8.
3. Nguyen T, Brownell W. Contribution of membrane cholesterol to outer hair cell wall stiffness. Hear Res 1998;119:14-20.
4. Sidman J, Prazma J, Pulver S, Pillsbury H. Cochlea and heart as end-organs in small vessel disease. Ann Otol Rhinol Laryngol 1988;97:9-13.
5. Axelsson A, Lindgren F. Is there a relationship between hypercholesterolemia and noise induced hearing loss. Acta Otolaryngol 1985;100:379-86.
6. Suckfüll M. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomized multicentre trial. Lancet 2002;360:1811-7.
7. Renders L, Mayer-Kadner I, Koch C, et al. Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients. Nephrol Dial Transplant 2001;16:141-6.
8. Dujovne CA, Harris WA, Altman R, Overhiser RW, Black DM. Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am J Cardiol 2000;85:350-3.
9. Goebel G, Hiller W. The tinnitus questionnaire (TQ). A standardized instrument for grading the severity of tinnitus. Results of a multi-center study using the TQ. HNO 1994;42:166-72.
10. Megighian D, Savastano M, Salvador L, Frigo A, Bolzan M. Audiometric and epidemiological analysis of elderly in the Veneto region. Gerontology 2000;46:199-204.